VAERS 2021 Database www.vaers.hhs.gov

Main Page | All 2021 Deaths | Videos
VAERS Updated: 11/12/2021
** VAERS DATABASE Last updated: November 12, 2021**
PLEASE CHECK BACK SOON
Download the files above while you wait.







Manufacturers

Total Manufacturer
199,106MODERNA
36,710JANSSEN
5,381PFIZER\BIONTECH
2,555GLAXOSMITHKLINE BIOLOGICALS
1,469UNKNOWN MANUFACTURER
897MERCK & CO. INC.
627SEQIRUS, INC.
112DYNAVAX TECHNOLOGIES CORPORATION
91SANOFI PASTEUR
75NOVARTIS VACCINES AND DIAGNOSTICS
40EMERGENT BIOSOLUTIONS
14PAXVAX
12TEVA PHARMACEUTICALS
12PROTEIN SCIENCES CORPORATION
9PFIZER\WYETH
4BERNA BIOTECH, LTD.
4SMITHKLINE BEECHAM
3INTERCELL AG
1MEDIMMUNE VACCINES, INC.
1CSL LIMITED

COVID19 Lot Number

VAX LOT Total
2S9CL7,949
7,473
2,547
1,506
1,187
1,051
1,049
s0294561,043
866
IMM209861
816
UT7065MA766
657
579
U62828AA563
557
538
U6737AA516
515
S034636506
4F472471
458
P100253275449
444
276563436
429
418
4BH32414
MENVEO404
PP9L5362
UJ446AA337
319
306
290
271
49TM3270
R1B252M253
4F472179
933622147
C5763AA144
CW3116134
3Y7NL126
UNK114
113
ARBA141A105
104
103
96
300057A90
79
1F4EB73
R1B743M62
56
UJ090AA55
51
UH894AB46
45
UNK44
UNK42
42
EJ168638
Unknown36
35
34
32
32
26
el128424
24
A115A22
22
EN620222
21
UNK20
20
19
Z127A19
19
17
JEV18K95E15
12
111798PI12
10
A739088
No batch number8
3333324181078
6
6
TAR356
5
5
U6935AA5
UNK5
4
unknown4
3
2
55RB72
2
2
2
2
2
U7124AA2
JEV18A68E2
2
ABYB05BA1
1
1
1
1
AMVA436A1
1
1
TJ3521
A130A; VIS give1
1
U7140BB1
1
1
SP UP016AA1
1
1808P08802/ESV01
037K20A300,947
EL1284288,578
57,766
1,432

Incidents per State

State Total
82,750
CA62,821
FL38,209
TX36,512
NY34,921
PA23,646
IN23,622
IL20,597
MI19,590
OH19,426
NJ18,413
NC16,769
GA15,932
WA15,351
VA15,234
MA14,876
AZ14,206
MN12,940
MD12,656
CO11,908
WI11,425
MO10,240
TN9,685
OR8,768
KY8,437
CT8,300
SC6,700
OK6,293
AL5,692
LA5,025
IA4,825
KS4,821
UT4,637
NV4,374
NM3,967
AR3,807
ME3,161
NH3,096
NE2,918
MS2,859
ID2,785
WV2,469
HI2,459
PR2,417
MT2,414
RI2,076
DE1,868
AK1,830
VT1,734
DC1,715
ND1,388
SD1,269
WY866
GU118
VI69
AS47
MP29
MH8
XB6
FM4
QM3
XV2
XL1

ID: 1652182
Sex: F
Age:
State: IL

Vax Date: 05/21/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dysphagia, Epiglottitis

Symptoms: Large bruise about 1 1/4 inch in diameter at the injection site of the vaccine; This is a spontaneous report from a contactable consumer, the patient. A 54-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the left arm on 21May2021 at 17:00 (at the age of 54-years-old) as a single dose for COVID-19 immunisation. Medical history included hashimotos thyroid disease. Patient previously took azithromycin (ZYTHROMAX) and nitrofurantoin (MACROBID) and experienced drug allergy. Concomitant medications included torasemide (TORSEMIDE), levothyroxine sodium 88 mg (SYNTHROID), ascorbic acid, calcium carbonate (CAL C) and vitamins nos (MULTIPLE VITAMIN); all for an unknown indication and from an unknown start date. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 22May2021 at 06:00, the patient experienced large bruise about 1 1/4 inch in diameter at the injection site of the vaccine. The patient did not receive any treatment for the event. The clinical outcome of the event large bruise about 1 1/4 inch in diameter at the injection site of the vaccine was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: TORSEMIDE; SYNTHROID; CAL C; MULTIPLE VITAMIN

Current Illness:

ID: 1652183
Sex: F
Age:
State: UT

Vax Date: 05/16/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025L20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Anxiety, Dyspnoea

Symptoms: Extreme muscle fatigue and soreness; Extreme muscle fatigue and soreness; Inappropriate schedule of vaccine administered; This is a spontaneous report from a contactable nurse, the patient. A 25-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8736) via an unspecified route of administration in the right arm on 16May2021 at 16:00 (at the age of 25-years-old) as a single dose for COVID-19 immunisation. Concomitant medications taken within two weeks of vaccination included bupropion hydrochloride (WELLBUTRIN) and fluticasone propionate (FLONASE) both from unknown date for unknown indication. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN5318) via an unspecified route of administration in the right arm on 29Jan2021 at 12:00 (at the age of 24-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17May2021 at 04:00, the patient experienced extreme muscle fatigue and soreness. The events resulted in doctor or other healthcare professional office/clinic visit. It was unknown whether therapeutic measures were taken as a result of the events. The clinical outcome of the events extreme muscle fatigue and soreness was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: WELLBUTRIN; FLONASE [FLUTICASONE PROPIONATE]

Current Illness:

ID: 1652184
Sex: M
Age:
State: NY

Vax Date: 03/27/2021
Onset Date: 03/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EL1284
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210327; Test Name: heart rate; Result Unstructured Data: Test Result:104-108/returned to my normal resting rate; Comments: increased beats per minute; Test Date: 20210405; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Chest discomfort, Dysphagia, Pain in extremity, Visual impairment

Symptoms: heart rate increased to 104-108 beats; didn't sleep well; felt tired; This is a spontaneous report from a contactable other-health care professional (Patient). A 60-year-old male patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EP6955 and expiration date was not reported), second dose via an unspecified route of administration, administered in arm left on 27Mar2021 10:15 (at the age of 60 years) as single for COVID-19 immunization. Medical history included HTN, GERD followed by known allergies (as yes) from an unknown date and unknown if ongoing. Patient Concomitants were not reported. Patient did not receive any other vaccines within 2 or 4 weeks prior to the COVID vaccine. Patient was not diagnosed with COVID-19, prior vaccination and since the vaccination. Historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection, Lot Number: EN5318 and expiration date was not reported), first dose via an unspecified route of administration, administered in arm left on 06Mar2021 11:15 (at the age of 59 years) as single for covid-19 immunisation caused insomnia, patient couldn't fall asleep until 4am that night. On 27Mar2021 21:00 the patient experienced heart rate increased to 104-108 beats which started 9pm the day of vaccine 2 and lasted until the next day about 2pm, didn't sleep well, felt tired. The patient underwent lab tests and procedures which included heart rate found to be 104-108/returned to my normal resting rate on 27Mar2021 (increased beats per minute) and Nasal Swab test found to be negative on 05Apr2021. The outcome of the events was found be recovered on unspecified date of 2021. No follow-up attempts are possible. No further information is expected

Other Meds:

Current Illness:

ID: 1652185
Sex: F
Age:
State: NY

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: unknown
Dose Series: UNK
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Dizziness, Fatigue, Mobility decreased

Symptoms: Fever; Joint pain; I couldnt sleep/I cant sleep; Joint muscle pain; Dizziness; This is a spontaneous report from a contactable consumer (patient). A 47-years-old female patient received BNT162B2 (FIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on 21May2021 17:00 (age at the vaccination 47-years-old) (Batch/Lot Number: EW0186) as DOSE 2, SINGLE for covid-19 immunisation. Medical history included allergy to penicillin. The patient's concomitant medications were not reported. The patient had not been tested for COVID-19 since the vaccination. The patient was not diagnosed with COVID-19 prior to vaccination. Patient did not received any other vaccines within 4 weeks prior to the COVID vaccine. On an unspecified date, patient received BNT162B2 (FIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 1 via an unspecified route of administration, administered in leg Right (Batch/Lot Number: EW0186) as DOSE 1, SINGLE for covid-19 immunisation and patient could not sleep. On 21May2021, after few minutes of the vaccine she had some dizziness on the (Facility) Center. On 22May2021 at 01:00, patient experienced fever, joint pain, joint muscle pain and couldn't sleep. It was reported that patient took Tylenol. Adverse event result doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of fever, joint pain, joint muscle pain and dizziness. At the time of this report, the outcome of events was unknown. Follow-up attempts are completed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652186
Sex: M
Age:
State: PA

Vax Date: 05/20/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: Throat is very itchy; This is a spontaneous report from a contactable consumer, the patient. A 40-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: Er8735) via an unspecified route of administration in the left arm on 20May2021 at 16:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Medical history included gastroesophageal reflux disease (GERD) and blood pressure high on an unknown date and unknown if ongoing. Concomitant medications included lisinopril (MANUFACTURER UNKNOWN); atorvastatin (MANUFACTURER UNKNOWN) and omeprazole (PRILOSEC) all for an unknown indication from an unknown date and unknown if ongoing. The patient was not allergic to medications, food, or other products. The patient also received unspecified nasal drip as concomitant medication. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, lot number: EW0161) via an unspecified route of administration in the left arm on 29Apr2021 at 09:00 (at the age of 40-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 18:00, the patient experienced very itchy throat. The patient reported that the event was perhaps from nasal drip or allergy reaction due to the shot. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken as a result of the reported events. The clinical outcome of the event very itchy throat was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: LISINOPRIL; ATORVASTATIN; PRILOSEC [OMEPRAZOLE]

Current Illness:

ID: 1652187
Sex: F
Age:
State: NY

Vax Date: 04/19/2021
Onset Date: 04/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: FLUC4
Manufacturer: SEQIRUS, INC.
Vax Name: INFLUENZA (SEASONAL) (FLUCELVAX QUADRIVALENT)
Lot: 276563
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Confusional state, Eye inflammation, Headache, Laboratory test

Symptoms: Fever; swollen lymph nodes; euphoria; out of body experiences; joint pain; swollen joints; muscle pain; chills; headache; stomachache; diarrhea; disequilibrium; shingles; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8735) via an unspecified route of administration in the right arm on 19Apr2021 at 14:30 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. Medical history included hypothyroid. Concomitant medications included levothyroxine sodium (SYNTHROID) since an unknown date. The patient previously received NSAIDs in the past used for unknown indication and on an unknown date and experienced an allergy to analgesics. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 19Apr2021 at 14:45, the patient experienced fever, swollen lymph nodes, euphoria, out of body experiences, joint pain, swollen joints, muscle pain, chills, headache, stomach ache, diarrhea, disequilibrium and shingles. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. The clinical outcome of the events fever, swollen lymph nodes, euphoria, out of body experiences, joint pain, swollen joints, muscle pain, chills, headache, stomach ache, diarrhea, disequilibrium, shingles were not resolved at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0168) via an unspecified route of administration in the right arm on 11May2021 at 14:30 (at the age of 60-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: SYNTHROID

Current Illness:

ID: 1652188
Sex: F
Age:
State:

Vax Date: 04/21/2021
Onset Date: 04/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pyrexia, White blood cell count decreased

Symptoms: severe chills; joint pain; headache for 10 straight days; sweating; fatigue; muscle weakness; This is a spontaneous report from a non-contactable consumer, the patient. A 46-year-old female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on 21Apr2021 (at the age of 46-years-old) as a single dose for COVID-19 immunisation. Medical history included disorder thyroid (Thyroid disease). Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21Apr2021 at 22:00, the patient experienced severe chills, joint pain, headache for 10 straight days, sweating, fatigue, muscle weakness. The patient did not receive any treatment for the events. The clinical outcome of events severe chills, joint pain, sweating, fatigue, muscle weakness recovered on an unspecified date in 2021. Headache recovered on 30Apr2021. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652189
Sex: M
Age:
State: WA

Vax Date: 05/21/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 20210523; Test Name: Body temperature; Result Unstructured Data: Test Result:101 Units:{DF}; Comments: woke up at 8:30am with a 101 degree fever; Test Name: COVID-19 test; Test Result: Negative ; Comments: Nasal Swab

Allergies:

Symptom List: Pharyngeal swelling

Symptoms: I slept until morning and woke up at 8:30am with a 101 degree fever and chest pain of 5/10.; I slept until morning and woke up at 8:30am with a 101 degree fever and chest pain of 5/10. Pain was centered near my sternum and felt as though someone had punched me in my chest. Once I took some tylenol and moved around it somewhat better.; On the 22 I had normal side effects such as sore arm and fatigue during the day. Around 8pm my side effects began to increase and I went to bed.; On the 22 I had normal side effects such as sore arm and fatigue during the day. Around 8pm my side effects began to increase and I went to bed.; This is a spontaneous report from a contactable healthcare professional, the patient. A 27-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWQ177) via an unspecified route of administration in the left arm on 21May2021 at 15:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Medical history included bipolar disorder and migraine. Concomitant medications taken within two weeks of vaccination included quetiapine fumarate (SEROQUEL) and valproate semisodium (DEPAKOTE), both from unknown date for unknown indication. The patient previously took Prochlorperazine (reported as compazine) and Triptan both for unknown indication and experienced drug allergy. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EWQ158) via an unspecified route of administration in the left arm on 28Apr2021 at 13:00 (at the age of 27-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient received second vaccine on 21May2021. Felt normal that day. On the 22May2021, the patient had normal side effects such as sore arm and fatigue during the day. Around 20:00 his side effects began to increase and the patient went to bed. The patient slept until morning and woke up on 23May2021 at 08:30 with a 101degree (unspecified units) fever and chest pain of 5/10. Pain was centered near the sternum and felt as though someone had punched him in the chest. Once he took some tylenol and moved around it was somewhat better. At 23:00 on the 23May2021, the patient felt better but still some mild chest pain. The patient had notified his physician. The patient missed work on the day of report due to chest pain. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of chest pain and included treatment with tylenol. On an unknown date post vaccination, the patient underwent COVID-19 test via nasal swab and the result was negative. The clinical outcome of the events had normal side effects such as sore arm and fatigue during the day, around 20:00 side effects began to increase and went to bed, slept until morning and woke up at 08:30 with a 101degree (unspecified units) fever and chest pain of 5/10 was resolving at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds: SEROQUEL; DEPAKOTE.

Current Illness:

ID: 1652190
Sex: F
Age:
State: OH

Vax Date: 03/05/2021
Onset Date: 05/09/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Abdominal pain, Chills, Sleep disorder

Symptoms: Shingles; This is a spontaneous report from a contactable consumer, the patient. A 75-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6200) via an unspecified route of administration in the left arm on 05Mar2021 at 10:15 (at the age of 75-years-old), as a single dose for COVID-19 immunisation. Medical history included type 2 diabetes mellitus, hypertension, obesity, thyroid nodules and seasonal allergies. Concomitant medications included acetylsalicylic acid (ASPIRIN) 325mg daily, insulin (MANUFACTURER UNKNOWN) and salbutamol (ALBUTEROL) prn; all for unspecified indication from unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EL9267) via an unspecified route of administration in the left arm on 12Feb2021 at 09:45 (at the age of 75-years-old), as a single dose for COVID-19 immunisation. The patient previously took cefixime (SUPRAX), clarithromycin (BIAXIN), lisinopril (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and fluticasone propionate;salmeterol xinafoate (ADVAIR DISCUS) for unspecified indication from unknown date and experienced drug allergy to cefixime (SUPRAX), clarithromycin (BIAXIN), lisinopril (MANUFACTURER UNKNOWN), losartan (MANUFACTURER UNKNOWN) and fluticasone propionate;salmeterol xinafoate (ADVAIR DISCUS) on unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 09May2021, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with valacyclovir & gabapentin. The clinical outcome of the event shingles was not recovered at the time of reporting. No follow-up attempts are needed. No further information is expected.

Other Meds: ASPIRIN [ACETYLSALICYLIC ACID]; INSULIN; ALBUTEROL [SALBUTAMOL]

Current Illness:

ID: 1652191
Sex: F
Age:
State: CT

Vax Date: 05/08/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J201A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Diarrhoea, Nasal congestion

Symptoms: My period started on May 11th and ended on May 15th (normal cycle). I then had a second period start on May 20th. My cycle is regular and this is not something that commonly occurs. I have not had a; This is a spontaneous report from a contactable consumer, the patient. A 39-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 08May2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Medical history included supraventricular tachycardia (SVT) and shellfish allergy. Concomitant medications included diltiazem (MANUFACTURER UNKNOWN) for unknown indication and from an unknown date. The patient previously received codeine (MANUFACTURER UNKNOWN) for unknown indication on an unknown date and experienced drug allergy. The patient previously received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0162) via an unspecified route of administration in the left arm on 17Apr2021 at 15:00 (at the age of 39-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient's period started on 11May2021 and ended on 15May2021 which was normal cycle. The patient then had a second period on 20May2021. The patient cycle was regular and this was not something that commonly occurs. The patient not had any medicine changes or illnesses. The event did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event, period started on 11May2021 and ended on 15May2021 which was normal cycle, had a second period on 20May2021 and cycle was regular and this was not something that commonly occurs was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: DILTIAZEM

Current Illness:

ID: 1652192
Sex: F
Age:
State: CO

Vax Date: 05/18/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Vaccination site erythema, Vaccination site pruritus, Vaccination site swelling

Symptoms: Nausea; Dizziness; tired; fever; unwell; tachycardia; bruised injection site; bruised injection site but it was only mildly tender; This is a spontaneous report from a contactable nurse, the patient. A 51-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: TLC612Y) via an unspecified route of administration in the left arm on 18May2021 at 10:00 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19 in Nov2020 and the patient did not have any other relevant medical history. The patient had no known allergies. Concomitant medications were not reported. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 19May2021 at 04:00, 16 hours after the first dose, the patient experienced nausea and dizziness which had gone by 3 hours. On the same day, the patient experienced tired, fever which was resolved with ibuprofen and the patient was unwell, had some feelings of tachycardia similar to when she had COVID. She was still active that day though, 48 hours later she felt fairly well and 72 hours later she felt mostly normal, though she still had occasional feelings of tachycardia and she also had a bruised injection site but it was only mildly tender. Therapeutic measures were taken as a result of fever and included treatment with ibuprofen. The events did not result in any of these doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events nausea and dizziness were resolved on 19May2021 at 07:00, while the clinical outcome of the events tired, fever, unwell, bruised injection site mildly tender were resolved on an unknown date in May2021 and tachycardia was resolving at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652193
Sex: M
Age:
State: AR

Vax Date: 05/19/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039k20a
Dose Series: 1
Vax Route: SYR
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Rash, Urticaria

Symptoms: Soreness under the arm from armpit of injection site.; This is a spontaneous report from a contactable consumer, the patient. A 15-year-old male patient received unknown dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0187) via an unspecified route of administration in the arm right on 19May2021 at 09:30(at the age of 15-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications included atomoxetine hydrochloride (STRATTERA) from an unknown date for an unknown indication. The patient had no known allergies. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 08:00, the patient experienced soreness under the arm from armpit of injection site. The patient received treatment for the reported events which included ice pack and was continued to monitor. The adverse event did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. The clinical outcome of the event soreness under the arm from armpit of injection site was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: STRATTERA

Current Illness:

ID: 1652194
Sex: F
Age:
State: AL

Vax Date: 04/01/2021
Onset Date: 04/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Blood pressure decreased, Chest pain, Chills, Confusional state, Decreased appetite

Symptoms: Dose 1 Apr2021 + Dose 2 Apr2021; Onset of acute Tachycardia after second dose of Pfizer vaccine; hypertensive; diagnosed with "Sinus Tachycardia".; This is a spontaneous report from a contactable consumer or other non-health care professional (patient). A 62-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, solution for injection), dose 2 via an unspecified route of administration, administered in Arm Right on Apr2021 (at the age of 62 years), (Batch/Lot number was not reported) as dose 2, single and dose 1 via an unspecified route of administration, administered in Arm Right on Apr2021 (at the age of 62 years), (Batch/Lot number was not reported) as dose 1, single for covid-19 immunisation in hospital. The patient was not pregnant at the time of vaccination. Medical history included hypertension, obesity, Mitral Valve Prolaspe from an unknown date and unknown if ongoing, Known allergies: Sulfa. Concomitant medication included atenolol, hctz and lisinopril taken for an unspecified indication, start and stop date were not reported. The patient previously took codeine and experienced drug hypersensitivity. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 08Apr2021 08:00 the patient experienced, Onset of acute Tachycardia after second dose of Pfizer vaccine. Heart rate sustaining at 100 and over. Also, hypertensive. Acute episode of Tachycardia not responding to new medications to help (Norvasc 5mg/day, Lisinopril 40mg/day, HCTZ 25mg/day, Metoprolol ER 25mg/day had been to the local Emergency Room and diagnosed with "Sinus Tachycardia". The events resulted in visit to Doctor or other healthcare professional office/clinic visit, Emergency room/department or urgent care. Therapeutic measures were taken as a result of onset of acute tachycardia after second dose of Pfizer vaccine, diagnosed with "sinus tachycardia" as Lopressor and Metoprolol. The clinical outcome of the event Onset of acute Tachycardia after second dose of Pfizer vaccine was unknown and remaining all other events was not recovered at the time of report. Follow-up attempts are completed. No further information is expected.

Other Meds: ATENOLOL; HCTZ; LISINOPRIL

Current Illness:

ID: 1652195
Sex: F
Age:
State: MT

Vax Date: 05/11/2021
Onset Date: 05/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20-2A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Dyspnoea, Fatigue, Feeling abnormal, Head discomfort, Headache

Symptoms: fever; weakness; fatigue; dizziness; arm was sore for several days after the injection; This is a spontaneous report from a contactable consumer, the patient. A 38-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0167) via an unspecified route of administration in the left arm on 11May2021 at 13:00 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Medical history included allergy to animal muscle like a steak but the patient could eat eggs and broths. Concomitant medications included escitalopram (MANUFACTURER UNKNOWN) and one a day woman's multivitamin; both from an unknown date and unknown if its ongoing. The patient previously received TYLENOL for unknown indication and experienced drug allergy. The patient previously received other vaccine in four weeks which included the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot number: EW0167) via an unspecified route of administration in the left arm on 20Apr2021 at 13:15 (at the age of 38-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 11May2021 at 19:30, the patient got fever, weakness, fatigue, and dizziness about 5 hours after the vaccine until the following evening. The patient said that it probably lasted 18 to 26 hours. The patient's arm was sore for several days after the injection. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events fever, weakness, fatigue, dizziness and arm was sore for several days after the injection were recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: ESCITALOPRAM

Current Illness:

ID: 1652196
Sex: F
Age:
State:

Vax Date: 05/22/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Heart rate decreased, Heart rate increased, Hypertension, Injection site pain, Musculoskeletal chest pain

Symptoms: Nose bleeding about 12 hours after injection; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: UNKNOWN), via an unspecified route of administration in the left arm on 22May2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. Prior to vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 22Mar2021, the patient experienced nose bleeding about 12 hours after the injection. Since the vaccination, the patient had not been tested for COVID-19. The adverse event resulted in a visit to the emergency room/department or urgent care. Therapeutic measures were not taken as the result of the event. The clinical outcome of the event nose bleeding was resolving at the time of this report. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds:

Current Illness:

ID: 1652197
Sex: F
Age:
State: CA

Vax Date: 04/09/2021
Onset Date: 04/11/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Date: 202104; Test Name: EKG; Result Unstructured Data: Test Result:Normal; Comments: EKG is normal; Test Date: 20210428; Test Name: Nasal Swab; Test Result: Negative

Allergies:

Symptom List: Nausea, Pain, Pain in extremity, Paraesthesia oral, Pyrexia

Symptoms: Difficulty in breathing; Increased heart rate; This is a spontaneous report from a contactable consumer, the patient. A 30-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0153) via an unspecified route of administration in the left arm on 09Apr2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient was allergic to seafood. Concomitant medications included vitamin D (MANUFACTURER UNKNOWN) and ascorbic acid (VITAMIN C), both taken for unspecified indications from unknown dates. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ED6955) via an unspecified route of administration in the left arm on 19Mar2021 (at the age of 30-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 11Apr2021, two days after the second vaccination, the patient experienced difficulty in breathing and increased heart rate. She monitored for any other symptoms and waited for a week to see if it would subside but the frequency increased in a week. After 2 weeks, the patient went to the doctor's office and got it checked. On an unknown date in Apr2021, the patient underwent EKG and the result was normal but she still had difficulty breathing few days after. The patient just wanted to make sure that she had no lingering or underlying side effect after that. The events resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were not taken as a result of the events. On 28Apr2021, the patient underwent COVID-19 test (nasal swab) and the result was negative. The clinical outcome of the events difficulty in breathing and increased heart rate were resolved on an unknown date in 2021. No follow-up attempts are needed. No further information is expected.

Other Meds: VITAMIN D NOS; VITAMIN C [ASCORBIC ACID]

Current Illness:

ID: 1652198
Sex: F
Age:
State:

Vax Date: 05/08/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: DTAPHEPBIP
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: DTAP + HEPB + IPV (PEDIARIX)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210516; Test Name: Neurological test; Result Unstructured Data: Test Result:Normal; Comments: Normal neurological test; Test Date: 20210516; Test Name: Blood work; Result Unstructured Data: Test Result:Normal; Comments: No abnormal blood work; Test Date: 20210522; Test Name: Blood test; Result Unstructured Data: Test Result:Pending; Comments: Blood test

Allergies:

Symptom List: SARS-CoV-2 antibody test, SARS-CoV-2 test negative

Symptoms: Constant headache beginning a week after the second dose; This is a spontaneous report from a non-contactable consumer, the patient. A 21-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the arm left on 08May2021 at 11:00 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. The patient had no relevant medical history. Concomitant medications were not reported. The patient had no known allergies to medications, food or other products. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0171) via an unspecified route of administration in the arm left on 17Apr2021 at 09:00 (at the age of 21-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021 at 13:00, the patient experienced constant headache beginning a week after the second dose received on 08May2021, headache beginning 16May2021. The patient took a visit to the emergency room, no abnormal blood work, normal neurological test. The event resulted in doctor or other healthcare professional office or clinic visit and emergency room or department or urgent care. Therapeutic measures were taken as a result of the event constant headache and included treatment with NSAID. On 22May2021, the patient underwent COVID-19 blood test and the result was pending. The clinical outcome of the event constant headache beginning a week after the second dose was not resolved at the time of reporting. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652199
Sex: F
Age:
State: OR

Vax Date: 05/22/2021
Onset Date: 05/25/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: HIBV
Manufacturer: MERCK & CO. INC.
Vax Name: HIB (PEDVAXHIB)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data:

Allergies:

Symptom List: Ear pain, Hypoaesthesia

Symptoms: Redness; Itching (localized allergic reaction) at shot site; This is a spontaneous report from a contactable consumer, the patient. A 48-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 22May2021 at 09:15(at the age of 48-year-old) as a single dose for COVID-19 immunisation. Medical history included hay fever, and patient was allergic to fenugreek. The patient did not receive any medication within two weeks of vaccination. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Unknown) via an unspecified route of administration in the left arm on 30Apr2021 at 09:15(at the age of 48-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 25May2021, on day 3 of the shot the patient experienced, 2 diameter redness and itching (localized allergic reaction) at shot site. It was unknown if therapeutic measures were taken as a result of adverse events. The clinical outcome of the events redness and itching at vaccination site was not recovered. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652200
Sex: F
Age:
State: OH

Vax Date: 04/12/2021
Onset Date: 04/13/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: PNC13
Manufacturer: PFIZER\WYETH
Vax Name: PNEUMO (PREVNAR13)
Lot:
Dose Series: UNK
Vax Route:
Vax Site: LG

Lab Data: Test Date: 20210413; Test Name: body temperature; Result Unstructured Data: Test Result:Low grade fever

Allergies:

Symptom List: Abdominal pain upper, Dizziness, Dysgeusia

Symptoms: Low grade fever, migraine head ache, chills, body aches for two days after my second shot.; body aches for two days after my second shot; migraine; headache; chills; This is a spontaneous report from a non-contactable consumer (patient). A 45-years-old non-pregnant female patient received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 2 via an unspecified route of administration, administered in Arm Left on 12Apr2021 at 09:00 AM (Batch/Lot Number: ER8734) as DOSE 2, SINGLE (at the age of 45-years-old) for COVID-19 immunisation. The patient's medical history included Under active thyroid from an unknown date and unknown if ongoing. Concomitant medications included levothyroxine 25 mcg tablet, vitamin D3 50 mcg. The patient had no known Allergies. The patient's historical vaccine included bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection), dose 1 via an unspecified route of administration, administered in Arm Left on 22Mar2021 at 09:00 AM (Batch/Lot Number: EP7534) as DOSE 1, SINGLE (at the age of 45-years-old) for COVID-19 immunisation. On 13Apr2021 at 03:00 hours, the patient experienced low grade fever, migraine headache, chills, body aches for two days after the second shot. The patient underwent lab tests and procedures which included body temperature: low grade fever on 13Apr2021. The adverse events resulted in doctor or other healthcare professional office/clinic visit. The events were non serious and did not result in death/Life threatening/Caused/prolonged hospitalization/Disabling/Incapacitating/Congenital anomaly/birth defect. The patient received no treatment for the adverse events. The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient has not been tested for COVID-19. The patient had recovered from the adverse events on 15Apr2021. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; VITAMIN D3

Current Illness:

ID: 1652201
Sex: F
Age:
State:

Vax Date:
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: RV1
Manufacturer: GLAXOSMITHKLINE BIOLOGICALS
Vax Name: ROTAVIRUS (ROTARIX)
Lot:
Dose Series: 1
Vax Route: PO
Vax Site: MO

Lab Data:

Allergies:

Symptom List: Blood pressure increased, Chest discomfort, Heart rate increased

Symptoms: Overall flu like symptoms; Weakness; Extreme muscle aches; Slight headache; Fatigue; This is a spontaneous report from a non-contactable consumer, the patient. A 34-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on an unknown date (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Medical history and concomitant medications were not reported. The patient previously took first dose of BNT162B2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date (at the age of 34-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. On 21May2021 at 23:00, the patient experienced extreme muscle aches, weakness, slight headache, fatigue, overall flu like symptoms. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the events extreme muscle aches, weakness, slight headache, fatigue, overall flu like symptoms was unknown. No follow-up attempts are possible; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness:

ID: 1652202
Sex: F
Age:
State: VA

Vax Date: 04/29/2021
Onset Date: 05/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: Eh9899
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pruritus, Injection site swelling, Lymph node pain, Lymphadenopathy

Symptoms: Nausea; Fatigue; Dizziness; Vertigo; Chills; Night sweats; Throat itchy; This is a spontaneous report from a non-contactable consumer, the patient. A 41-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 29Apr2021 at 13:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included fexofenadine hydrochloride (ALLEGRA), fluticasone propionate (FLONASE), ascorbic acid (VITAMIN C), multi-vitamins (MANUFACTURER UNKNOWN) and zinc (MANUFACTURER UNKNOWN) for unknown indication from an unknown date. The patient had no known allergies to medications, food or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 20May2021 at 19:00 the patient experienced all sick symptoms nausea, fatigue, dizziness, vertigo, chills, night sweats and throat itchy. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events nausea, fatigue, dizziness, vertigo, chills, night sweats and throat itchy was recovering at the time of this report. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21May2021 at 13:00 (at the age of 41-year-old) as a single dose for COVID-19 immunisation. No follow-up attempts are possible; information about lot/batch number cannot be obtained. No further information is expected.

Other Meds: ALLEGRA; FLONASE [FLUTICASONE PROPIONATE]; VITAMIN C [ASCORBIC ACID]; ZINC

Current Illness:

ID: 1652203
Sex: M
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Unevaluable event

Symptoms: Neck has been hurting; My head hurts; Bad back pain down my spinal cord; some back pain in my body; This is a spontaneous report from a contactable male consumer reported for himself. A male patient of unspecified age received an unknown dose of bnt162b2 (Pfizer COVID-19 Vaccine, Solution for injection, Batch/lot number: EW0168, Expiration date: Unknown), via an unspecified route on an unknown date (Sunday), as a single dose for covid-19 immunization. The patient medical history and concomitant medications were not reported. On an unknown date, patient neck has been hurting, his head hurts and he got bad back pain down his spinal cord, some back pain in body too bad and he 'haven't been currently taken anything (voice feeble). The clinical outcome of the events was unknown. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652204
Sex: M
Age:
State: NH

Vax Date: 05/21/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Injection site pain, Myalgia, Pyrexia

Symptoms: 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; 2 days of intermittent fevers, chills, injection site pain, weakness, inappetance, and today full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about 10 minutes.; This is a spontaneous report from a non-contactable consumer, the patient. A 43-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: Ew0168) via an unspecified route of administration in the right arm on 21May2021 at 15:15 (at the age of 43-years-old) as a single dose for COVID-19 immunisation. Medical history included asthma. Concomitant medications taken within two weeks of vaccination included dextromethorphan hydrobromide, doxylamine succinate, ephedrine sulfate, ethanol, paracetamol (NYQUIL) from unknown date for unknown indication. The patient previously took acetylsalicylic acid (ASPIRIN) and ibuprofen, both for unknown indication and experienced drug allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 22May2021 at 06:00, the patient experienced two days of intermittent fevers, chills, injection site pain, weakness, inappetance, and on 23May2021, the day of report full body muscle spasms/cramps. First episode lasting over an hour, second episode lasted about ten minutes. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. No therapeutic measures were taken as a result of the events. The clinical outcome of the events two days of intermittent fevers, chills, injection site pain, weakness, inappetance, and on the day of report full body muscle spasms/cramps; first episode lasting over an hour, second episode lasted about 10 minutes was unknown at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: NYQUIL

Current Illness:

ID: 1652205
Sex: F
Age:
State:

Vax Date: 05/05/2021
Onset Date: 05/05/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011L20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain, Pain

Symptoms: red spots/hives appeared all over body. They are not itchy or painful but are mildly scaly; Inappropriate schedule of vaccine administered to Dose 1:17Apr2021; Dose 2: 05May2021; This is a spontaneous report from a non-contactable consumer, the patient. A 36-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the right arm on 05May2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. The patient had allergy to cephalosporin antibiotics. Concomitant medications were not reported. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0158) via an unspecified route of administration in the left arm on 17Apr2021 (at the age of 36-year-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination the patient had not been tested for COVID-19. On 16May2021, about 10 days after 2nd dose the patient experienced red spots/hives appeared all over body. They are not itchy or painful but were mildly scaly. Patient had no other new illness, medication, vaccine, etc. or any other event (such as contact with an allergen like poison ivy) at that time period. As of 23May2021 they had not yet healed/gone away. The events did not result in doctor or other health care professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the event hives appeared all over the body was not resolved at the time of report. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652206
Sex: M
Age:
State: PA

Vax Date: 04/07/2021
Onset Date: 04/17/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data: Test Name: blood pressure; Result Unstructured Data: Test Result:high; Test Date: 20210518; Test Name: blood pressure; Result Unstructured Data: Test Result:still struggled with high blood pressure; Test Name: pulse; Result Unstructured Data: Test Result:high; Test Date: 20210518; Test Name: pulse; Result Unstructured Data: Test Result:still struggled with high pulse; Test Date: 20210518; Test Name: Antibody test; Result Unstructured Data: Test Result:Pending results; Test Date: 20210518; Test Name: tested for COVID-19; Result Unstructured Data: Test Result:Pending results

Allergies:

Symptom List: Injection site pain, Menorrhagia

Symptoms: Mental fogginess; high blood pressure; experience of tachycardia; high blood pressure and pulse; Extreme pain throughout entire spine; Psychotic event/ psychotic episode; Anxiety; compulsion; This is a spontaneous report from a contactable consumer (patient). A 58-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 VACCINE; lot number: EP7533) via an unspecified route of administration in the left arm on 07Apr2021 at 12:00 as dose 1, single and the second dose of BNT162b2 (lot number: ER8731) via unspecified route of administration in the left arm on 28Apr2021 at 12:00 as dose 2, single both for COVID-19 immunization, at the age of 58-years-old. Medical history included chronic pain after trauma, asthma and cataract lens replacement. The patient was allergic to minor corn, peppers and had multiple environmental allergies. Patient was also allergic to cefalexin (CEPHALEXIN) and had problem with it. Concomitant medications included oxycodone taken at 15mg, morphine sulfate (MORPHINE SULPHATE) taken at 15mg and cannabis sativa (MARIJUANA) which was reported as medical marijuana (MMJ), all taken for unspecified indications from unknown dates. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 17Apr2021 at 12:00, approximately 10 days after the first dose, the patient experienced anxiety and compulsion. On 21Apr2021, the patient experienced psychotic event that lasted for 3 days. On 25Apr2021, the following fourth day, the patient experienced extreme pain throughout entire spine that felt as if it was caused by an internal pressure. On 18May2021, patient still struggled with high blood pressure and pulse including experience of tachycardia, started on an unspecified date, during Doctor's appointment. On unspecified date, mental fogginess and anxiety was greater upon wakeup and lessened to almost decent before bedtime as of just a week prior the report. Patient saw magazine article referencing long-haulers possible link with antibody effect on some and felt this may be apropos with him as well. The patient could not feel that he could have coincidentally lost it yet with psychotic episode 14 days post first vaccination but, if it was antibody related it made sense to him. He was using diet in attempt to treat symptoms but did not share this information with others including doctors as yet. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. Since the vaccination, on 18May2021, the patient had been tested for COVID-19 and had antibody test and results were pending. The clinical outcome of the event psychotic event was resolved on 24Apr2021, while the clinical outcome of the other events was resolving at the time of this report. Follow-Up (18Aug2021): Follow-up attempts are completed. No further information is expected.

Other Meds: OXYCODONE; MORPHINE SULPHATE; MARIJUANA

Current Illness:

ID: 1652207
Sex: M
Age:
State: OH

Vax Date: 03/05/2021
Onset Date: 03/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Arthralgia, Chills, Headache, Mobility decreased, Myalgia

Symptoms: Autoimmune problems; Joints pain swelling; Joints pain/ wrists are very sore; Walking is hard; my hand have lost most grip strength; This is a spontaneous report from a contactable consumer, the patient. This 70-year-old male patient reported that he received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot number: unknown) via an unspecified route in the left arm on 05Mar2021 at 16:00 (at the age of 70-years-old) as a single dose for COVID-19 immunization. Medical history included gout (one every 18 months or so). The patient did not receive any other vaccines within 4 weeks prior to the COVID vaccine. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications the patient received within 2 weeks of vaccination included vitamin (unspecified product) and Tamsulosin hcl (FLOMAX). On 08Mar2021, 2 to 7 days after shot (as reported), the patient experienced autoimmune problems in most joints pain swelling. Patient reported that most symptoms are still with him more than 2.5 months. He reported walking is hard and his hand has lost most grip strength wrists are very sore. There was no treatment received for the events. The clinical outcome of the events was not recovered. Since the vaccination, the patient has not been tested for COVID-19. The lot number for the vaccine, BNT162B2, was not provided and will be requested during follow-up.

Other Meds: FLOMAX [TAMSULOSIN HYDROCHLORIDE]

Current Illness:

ID: 1652208
Sex: F
Age:
State:

Vax Date: 05/13/2021
Onset Date: 05/14/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Nausea, Pain in extremity, Pyrexia

Symptoms: Flu like symptoms; body aches; severe vertigo; nausea and fever lasting around 24 hours; nausea and fever lasting around 24 hours; This is a spontaneous report from a contactable consumer, the patient. A 19-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 13May2021 at 13:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Medical history included migraines, not severe. The patient was allergic to penicillin. Concomitant medications included acetylsalicylic acid, caffeine, paracetamol (EXCEDRIN) taken once weekly or less for an unspecified indication from an unknown date. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Solution for injection; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 15Apr2021 at 09:00 (at the age of 19-years-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 14May2021 at 08:00, the patient experienced flu like symptoms, body aches and severe vertigo, nausea and fever which lasted around 24 hours, vertigo and nausea lasted 24 hours after. The events did not result in a visit to the doctors or other healthcare professional office/clinic visit and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events flu like symptoms, body aches and fever were resolved on 15May2021, while the clinical outcome of the events severe vertigo and nausea were resolved an unknown date in May2021. Information about lot/batch number has been requested.

Other Meds: EXCEDRIN [ACETYLSALICYLIC ACID;CAFFEINE;PARACETAMOL]

Current Illness:

ID: 1652209
Sex: U
Age:
State:

Vax Date: 05/22/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Fatigue, Headache, Myalgia

Symptoms: having chills; my body is just sweating profusely; it feels as my head has like pressure all around it; my entire abdomen and lower back is sore; my body burning all through my leg; my entire abdomen and lower back is sore; I had chest pain; headache relevant symptoms; This is a spontaneous report from a contactable consumer (Patient). A patient of unspecified age and gender received bnt162b2 (PFIZER-BIONTECH COVID-19 VACCINE, formulation: solution for injection, Batch/Lot number was not reported), via an unspecified route of administration on 22May2021 as dose 2, single for covid-19 immunisation. The patient medical history and concomitant medications were not reported. On 22May2021 patient experienced chest pain, headache relevant symptoms and on 23May2021 patient having chills, body is just sweating profusely, it feels as my head has like pressure all around it, entire abdomen and lower back is sore, body burning all through my leg. It was reported that patient received second vaccine of Pfizer yesterday and would say that may be so it was even a headache relevant symptoms and going through the night, and now this morning, patient having chills, body is just sweating profusely, it feels as patient head has like pressure all around it, entire abdomen and lower back is sore and patient body burning all through my leg and had chest pain through the night. Patient asking So should I go to the doctor or what should I do. Patient have never tested positive for Covid. The outcome of all event was Unknown. Information on the lot/batch number has been requested

Other Meds:

Current Illness:

ID: 1652210
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data: Test Name: UTI test; Test Result: Negative ; Comments: Doctor tested for UTI but that was negative

Allergies:

Symptom List: Headache, Heart rate increased, Injection site erythema, Injection site pain, Injection site swelling

Symptoms: A few days after the first vaccination experienced painful and frequent urination; A few days after the first vaccination experienced painful and frequent urination; Vaginal itching; Abdominal pain; Feeling like bladder wass full but wasn't; This is a spontaneous report from a non-contactable consumer, the patient. A 44-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration on an unknown date, as a single dose for COVID-19 immunisation. The patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN6203) via an unspecified route of administration on 19Apr2021 (at the age of 44-years-old) as a single dose for COVID-19 immunisation. Other medical history not reported. The patient had no known allergies to medications, food, or other products. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any medications within two weeks of vaccination. The patient did not receive any other vaccines within four weeks prior to the vaccination. On an unknown date, few days after the first vaccination the patient experienced painful urination, frequent urination, vaginal itching, abdominal pain and "feeling like bladder was full but it wasn't". The patient had experienced the same events a few days after the second vaccination also. On an unknown date, the patient underwent lab test which included urine test for UTI and the result was negative. The events resulted in doctor or other healthcare professional office/clinic visit. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events painful urination, frequent urination, vaginal itching, abdominal pain and " feeling like bladder was full but it wasn't" was recovered on an unknown date. No follow-up attempts are possible. No further information is expected.

Other Meds:

Current Illness:

ID: 1652211
Sex: M
Age:
State:

Vax Date: 05/15/2021
Onset Date: 05/16/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Nausea

Symptoms: fever; chills; tired; arm red and swollenaround shot around,; arm red and swollenaround shot around,; swelling of armpit; This is a spontaneous report from a non-contactable consumer, the patient. A 14-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EN0168) via an unspecified route of administration in the left arm on 15May2021 at 12:00 (at the age of 14-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient had no known allergies. The patient did not receive other medications in two weeks of vaccination. Prior to the vaccination, the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 16May2021, the patient experienced fever, chills, tired, arm red and swollen around shot, swelling of armpit. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The patient did not receive any treatment for the events. The clinical outcome of the events fever, chills, tired, arm red and swollen around shot, swelling of armpit recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652212
Sex: F
Age:
State: NV

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: UNK
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site pain

Symptoms: Muscle spasms like charley horses in foot and calf; few back spasms; Numbness and tingling in hands; Numbness and tingling in hands; This is a spontaneous report from a non-contactable consumer, the patient. A 35-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0173) via an unspecified route of administration in the left arm on 21May2021 at 16:30 (at the age of 35-years-old) as a single dose for COVID-19 immunisation. Medical history included migraine. The patient had no known allergies. Concomitant medications included birth control pills (MANUFACTURER UNKNOWN), levothyroxine (MANUFACTURER UNKNOWN) and lamotrigine (MANUFACTURER UNKNOWN), all taken for unspecified indications from unknown dates. Prior to the vaccination, it was unknown whether the patient was diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 21May2021 at 22:00, the patient experienced muscle spasms like Charley horses that lasted for hours at a time in foot and calf, a few back spasms, numbness and tingling in hands like arm fell asleep even though not laying on it. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events muscle spasms like Charley horses in foot and calf, a few back spasms, numbness and tingling in hands were not resolved at the time of this report. No follow-up attempts are possible. No further information is expected.

Other Meds: LEVOTHYROXINE; LAMOTRIGINE

Current Illness:

ID: 1652213
Sex: F
Age:
State: AL

Vax Date: 05/21/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site induration, Injection site pruritus, Injection site swelling, Injection site warmth

Symptoms: yeast infection; This is a spontaneous report from a contactable consumer, the patient. A 27-year-old female patient received BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0178) via an unspecified route of administration in the left arm on 21May2021 at 09:45(at the age of 27-year-old) as a single dose for COVID-19 immunisation. Patient had allergy to amoxicillin family. Concomitant medications were not reported. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 23May2021 at 01:00 the patient experienced yeast infection. No therapeutic measures were taken as a result of the events. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. The clinical outcome of the event yeast infection was not resolved at the time of report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652214
Sex: F
Age:
State: IN

Vax Date: 05/22/2021
Onset Date: 05/22/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011j20a
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Dizziness, Nausea, Pain, Tachycardia

Symptoms: Shot sight red; Shot sight raised; Shot site tender to touch; This is a spontaneous report from a contactable consumer, the patient. A 60-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0187) via an unspecified route of administration in the left arm on 22May2021 at 13:45 (at the age of 60-years-old) as a single dose for COVID-19 immunisation. The patients' medical history included COVID-19. The patient had no known allergies to medications, food or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any medications within two weeks of the COVID-19 vaccination. The patient previously took the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8737) via an unspecified route of administration in the left arm on 05Apr2021 at 10:00 (at the age of 59-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the COVID-19 vaccination. On 22May2021 at 14:00, the patient experienced "shot sight red, raised and tender to touch". Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events "shot sight red, raised and tender to touch" was not resolved at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652215
Sex: M
Age:
State: ME

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Tremor

Symptoms: Slight itching on upper extremities; Developed a few hives; This is a spontaneous report from a contactable healthcare professional. A 66-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: ER8734) via an unspecified route of administration in the right arm on 21May2021 at 10:45(at the age of 66-years-old) as a single dose for COVID-19 immunisation. Medical history included hypertension, osteoarthritis and allergy to penicillin V. Patient previously took potassium (MANUFACTURER UNKNOWN), hydrochlorothiazide (MANUFACTURER UNKNOWN), fluticasone propionate (MANUFACTURER UNKNOWN) and experienced drug allergy. Concomitant medications included amlodipine besilate (AMLODIPINE BESYLATE) 10mg 1 tablet daily from unknown start date and for unspecified indication. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 21May2021 at 10:45, the patient experienced slight itching on upper extremities and developed a few hives. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of adverse events and included treatment with one dose of oral BENADRYL. The clinical outcome of the event slight itching on upper extremities and developed a few hives were recovered on an unknown date in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: AMLODIPINE BESYLATE

Current Illness:

ID: 1652216
Sex: M
Age:
State: AZ

Vax Date: 04/30/2021
Onset Date: 04/30/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Erythema, Pruritus

Symptoms: Slight fever; Fatigue; Very swollen and sore armpit lymph nodes on arm of injection; Rash in armpit (not on injection site); Headache; Achy; sore armpit lymph nodes on arm of injection; Injection site soreness; This is a spontaneous report from a contactable consumer, the patient. A 28-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the arm left on 30Apr2021 at 07:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. Medical history included depression and obesity. The patient did not have any allergies to medications, food, or other products. Concomitant medications included escitalopram oxalate (LEXAPRO), paracetamol (TYLENOL) and mefenamic acid (ADVIL); all started on unknown dates and for unknown indications. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the COVID vaccine. On 30Apr2021 at 07:30 the patient experienced injection site soreness immediately after the dose. On 09May2021 at 17:00, the patient experienced being achy, slight fever, fatigue, very swollen and sore armpit lymph nodes, and rash in armpit (not on injection site). armpit (not on injection site). The symptoms (outside of injection site soreness) were reported to be a sudden onset within an hour of the time reported earlier (17:00), a few days after injection. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. No therapeutic measures were taken for the reported events. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcome of the events injection site soreness, achy, very swollen and sore armpit lymph nodes on arm of injection, slight fever, fatigue, and rash in armpit (not on injection site) were resolving at the time of this report. The patient also received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the arm left on 21May2021 at 14:30 (at the age of 28-years-old) as a single dose for COVID-19 immunisation. No follow-up attempts are needed. No further information is expected.

Other Meds: LEXAPRO; TYLENOL; ADVIL [MEFENAMIC ACID]

Current Illness:

ID: 1652217
Sex: M
Age:
State: NY

Vax Date: 05/23/2021
Onset Date: 05/24/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: UNK
Manufacturer: UNKNOWN MANUFACTURER
Vax Name: VACCINE NOT SPECIFIED (NO BRAND NAME)
Lot:
Dose Series: UNK
Vax Route: SYR
Vax Site: UN

Lab Data: Test Date: 20210524; Test Name: Body temperature; Result Unstructured Data: Test Result:102 Units:[degF]; Comments: Time: 03:00

Allergies:

Symptom List: Injection site erythema, Injection site induration, Injection site pruritus, Injection site swelling, Myalgia

Symptoms: Headache; Dizziness; 102 Fahrenheit Fever; This is a spontaneous report from a contactable consumer, the patient. A 29-year-old male patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0183) via an unspecified route of administration in the left arm on 23May2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. Medical history included prawn's allergy. Prior to the vaccination, the patient was not diagnosed with COVID-19. Concomitant medication included ascorbic acid; calcium pantothenate; colecalciferol; cyanocobalamin; folic acid; nicotinamide; pyridoxine hydrochloride; retinol; riboflavin; thiamine hydrochloride; tocopheryl acetate (ONE A DAY MENS) from an unknown date for unknown indication and unknown if ongoing. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0172) via an unspecified route of administration in the left arm on 02May2021 at 10:00 (at the age of 29-years-old) as a single dose for COVID-19 immunisation. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 24May2021 at 03:00, the patient experienced headache, dizziness and a 102 Fahrenheit fever. Since the vaccination, the patient had not been tested for COVID-19. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. The clinical outcome of the events headache, dizziness and 102 Fahrenheit fever was not recovered at the time of this report. No follow-up attempts are needed. No further information is expected.

Other Meds: ONE A DAY MENS

Current Illness:

ID: 1652218
Sex: F
Age:
State: PA

Vax Date:
Onset Date: 04/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Cough, Limb discomfort, Pain, SARS-CoV-2 test positive

Symptoms: Breathing issues; Swollen lips; Severe hives in throat, in mouth and in nose. Very large on hives on face not going away; This is a spontaneous report from a contactable consumer (patient). A 51-year-old non-pregnant female patient received BNT162B2 (Lot. EP7534) on an unspecified date, in 2021, at single dose, for COVID-19 immunisation. COVID-19 vaccine was administered at Hospital. The patient had not received any other vaccines within 4 weeks prior to the BNT162B2 vaccine. Relevant medical history included multiple sclerosis from an unspecified date and sulfa allergy from an unspecified date. Prior to vaccination, the patient was not diagnosed with COVID-19. Concomitant medications were unknown. On 15Apr2021 at 17:30, the patient experienced breathing issues, swollen lips, severe hives in throat, in mouth and in nose. Very large on hives on face not going away. Physician office/clinic visit required. Treatment was received (high doses steroids). The patient did not recover from the adverse events at time of this report. Post the vaccination, the patient has not been tested for COVID-19.

Other Meds:

Current Illness:

ID: 1652219
Sex: M
Age:
State: MA

Vax Date: 04/18/2021
Onset Date: 05/01/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Asthenia, Chills, Headache, Myalgia

Symptoms: shingles; This is a spontaneous report from a contactable consumer, the patient. A 45-year-old male patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0164) via an unspecified route of administration in the arm left on 18Apr2021(at the age of 45-year-old) as a single dose for COVID-19 immunisation. Medical history included anxiety, depression and latex allergy. The patient received unspecified medication within two weeks of vaccination. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 01May2021 not long after the vaccination, the patient experienced shingles. The event resulted in doctor or other healthcare professional office/clinic visit. Therapeutic measures were taken as a result of shingles and included treatment with valacyclovir. The clinical outcome of the event shingles was recovering. No follow-up attempts are needed. No further information is expected.

Other Meds:

Current Illness:

ID: 1652220
Sex: F
Age:
State: ME

Vax Date: 05/23/2021
Onset Date: 05/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 011J20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site erythema, Injection site pain, Injection site swelling

Symptoms: Numbness in injected arm up, on side of neck and face; Fear; very lethargic feeling; Weakness; Increase fatigue; Headaches; This is a spontaneous report from a contactable consumer or other non hcp (patient). A 64-years-old non-pregnant female patient received the first dose of bnt162b2 (PFIZER-BIONTECH COVID-19 MRNA VACCINE, formulation: solution for injection) via an unspecified route of administration, administered in Arm Left on 23May2021 14:45 (at the age of 64-years-old) as single dose for covid-19 immunisation. Medical history included chronic whole-body pain associated with fibromyalgia, had a stroke 11 years ago, irritable bowel syndrome (IBS), gastroesophageal reflux disease (GERD), temporomandibular joint disorder (TMJ), arthritis, degenerative disc disease, fainting problems, fatigue and depression, chronic cough, many other health issues, environmental allergy, allergy to dogs, latex allergy and drug allergy (many medications). The patient's concomitant medications were not reported. The patient received other medicines (unspecified) within two weeks prior to the COVID-19 vaccine. On 23May2021 14:45, the patient experienced numbness in injected arm up, on side of neck and face, fear, very lethargic feeling, weakness, increase fatigue, headache. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. It was unknown whether therapeutic measures were taken as a result of the events. The outcome of all the events was not recovered. The lot number for the vaccine, [BNT162b2], was not provided and will be requested during follow up.

Other Meds:

Current Illness:

ID: 1652221
Sex: F
Age:
State:

Vax Date:
Onset Date:
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot: EK9231
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Chills, Feeling cold, Feeling hot, Myalgia, Pain

Symptoms: she lost strength in her left hand or more in the arm; She said she can't pick up nothing; Her hands also feels cold sometimes; she can't stand up right; This is a spontaneous report from a contactable consumer (patient) reported for herself that a 35-years-old female patient received first dose of BNT162B2 (Pfizer-Biontech COVID-19 Vaccine, Solution for injection, batch/ lot number: unknown, Expiry Date: unknown), via an unknown route of administration in left arm on an unknown date as single for COVID-19 immunisation. The patient's medical history and concomitant medications were not reported. On an unknown date, the patient lost strength in her left hand or more in the arm, she said she can't pick up nothing, her hands also feels cold sometimes and she can't stand up right. It was explained that the patient had the first dose of the vaccine and lost strength in her left arm and right arm, where she was vaccinated; especially in the left arm where the caller got the vaccine. Right hand also lost some strength but not like the left hand. She can't pick up nothing. She said the caller reported that the symptoms were gone and the caller was getting ready for the second dose this week. She said sometimes it get worse, especially in the shower: she can't stand up right or or that some days she wakes up and it's worse than others, can't pick up anything. The patient also reports that her hands and feet feel cold. She is asking if this is normal. Should she get the second dose or not. The outcome of the events was unknown. Information about batch/Lot number has been requested. No further information obtained.

Other Meds:

Current Illness:

ID: 1652222
Sex: F
Age:
State: WA

Vax Date: 05/06/2021
Onset Date: 05/08/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Pain in extremity

Symptoms: sore arm; nausea; was hardly able to eat and was feeling off; was hardly able to eat and was feeling off; severe vertigo; vomit; worst symptoms; This is a spontaneous report from a contactable consumer or other non hcp. A 25-years-old female patient received bnt162b2 (Formulation: Solution for injection; Batch/Lot Number: EW0173), dose 1 via an unspecified route of administration, administered in Arm Left on 06May2021 16:00 AM as DOSE 1, SINGLE for covid-19 immunisation. Medical history included allergy to Pineapple from an unknown date and unknown if ongoing. Concomitant medication included ethinylestradiol, levonorgestrel (SRONYX) taken for an unspecified indication, start and stop date were not reported. On 08May2021 04:00 consumer reported initial side effects were sore arm, and nausea. By Friday evening I was hardly able to eat and was feeling off. I woke up in the middle of the night out of sorts and the room was spinning. This subsided after a few hours, but then by Saturday at midnight/1am, I was experiencing severe vertigo and began to vomit. This took until Wednesday of the next week to subside entirely, but Saturday being the worst symptoms. They gradually improved everyday thereafter with use of dramamine, zofran, and valium at the ER (Saturday 08 May), then dramamine the following days as needed. The patient received treatment with Zofran, Meclazine, and Valium. The adverse event result in Emergency room/department or urgent care. Prior to vaccination, unknown if the patient diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The outcome of the event was unknown. Follow-up attempts completed. No further information expected.

Other Meds: SRONYX

Current Illness:

ID: 1652223
Sex: F
Age:
State: CA

Vax Date: 05/13/2021
Onset Date: 05/15/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 2
Vax Route:
Vax Site:

Lab Data:

Allergies:

Symptom List: Abdominal pain upper, Abnormal behaviour, Adverse reaction, Anger, Asthma

Symptoms: drying; peeling skin on face; Itchiness/severe itchiness; hives in arms; This is a spontaneous report from a contactable consumer, the patient. A 16-year-old non-pregnant female patient received the second dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0167 SHC-VC) via an unspecified route of administration in the right arm on 13May2021 at 00:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Medical history was not reported. Concomitant medications included diphenhydramine, paracetamol, phenylpropanolamine hydrochloride (BENADRYL) and hydrocortisone cream (MANUFACTURER UNKNOWN); both from an unknown date for an unspecified indication. The patient had no known allergies. The patient previously received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: EW0159) via an unspecified route of administration in the right arm on 22Apr2021 at 00:00 (at the age of 16-year-old) as a single dose for COVID-19 immunisation. Prior to the vaccination, the patient was not diagnosed with COVID-19. Since the vaccination, the patient had not been tested for COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. On 15May2021 at 13:00, 2 days after vaccination, the patient experienced itchiness, hives in arms. On 15May2021, on day 4, the patient experienced severe itchiness, drying and peeling skin on face. The events did not result in doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Therapeutic measures were taken as a result of the events and included treatment with OTC hydrocortisone cream and Benadryl. The clinical outcome of the events itchiness, hives in arms, severe itchiness, drying, and peeling skin were recovering. No follow-up attempts are needed. No further information is expected.

Other Meds: BENADRYL; HYDROCORTISONE

Current Illness:

ID: 1652224
Sex: M
Age:
State: GA

Vax Date: 05/19/2021
Onset Date: 05/19/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 039K20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Consciousness fluctuating, Crying, Dry skin, Epistaxis, Headache

Symptoms: Forehead skin, skin behind ear and, neck skin tighten right after shot.; pressure in both eyes; Sharp pain; pressure started at enter of chest, then it moved center left.; thumping in chest; Tired; not able to sleep; felt very hot even though inside temp was 70 F; This is a spontaneous report from a contactable consumer, the patient. A 51-year-old male patient received first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE, Lot Number: EW0182), via an unspecified route of administration in the right arm on 19May2021 at 15:45 (at the age of 51-years-old) as a single dose for COVID-19 immunisation. Medical history included COVID-19. The patient did not have any allergies to medications, food or other products. Prior to vaccination, the patient was diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. Concomitant medications included mometasone furoate (MANUFACTURER UNKNOWN) and hydrochlorothiazide (HCTZ) (MANUFACTURER UNKNOWN) for an unknown indication from an unknown date. On 19May2021 at 16:00, the patient experienced forehead skin, skin behind ear and, neck skin tightened right after shot, pressure in both eyes, sharp pain and pressure started at enter the chest, then it moved center left, could hear thumping in chest, tired but not able to sleep, felt very hot even though inside temp was 70 F. No therapeutic measures were taken as the result of adverse events. The adverse event did not result in a visit to the doctor or other healthcare professional office/clinic visit, and emergency room/department or urgent care. Since the vaccination, the patient had not been tested for COVID-19. The clinical outcomes of the events forehead skin, skin behind ear and, neck skin tighten right after shot, pressure in both eyes sharp pain and pressure started at enter of chest, could here thumping in chest, tired but not able to sleep felt very hot even though inside temp was 70 F was recovered in May2021. No follow-up attempts are needed. No further information is expected.

Other Meds: MOMETASONE FUROATE; HYDROCHLOROTHIAZIDE

Current Illness:

ID: 1652225
Sex: F
Age:
State: WV

Vax Date: 05/21/2021
Onset Date: 05/21/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025J20A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data: Test Name: Nasal swab; Test Result: Negative

Allergies:

Symptom List: Hypotonia, Lethargy, Respiratory rate decreased, Screaming, Skin warm

Symptoms: lips had swollen; throat is sore; arm pain; extremely tired; This is a spontaneous report from a contactable healthcare professional, the patient. A 29-year-old non-pregnant female patient received the first dose of BNT162b2 (PFIZER-BIONTECH COVID-19 mRNA VACCINE; Lot Number: UNKNOWN) via an unspecified route of administration in the left arm on 21May2021 at 16:30 (at the age of 29-year-old) as a single dose for COVID-19 immunisation. Medical history included asthma and allergy to hazelnut and cashews. Prior to the vaccination, the patient was not diagnosed with COVID-19. The patient did not receive any other vaccines within four weeks prior to the vaccination. The patient did not receive any medication within two weeks of vaccination. On 21May2021 at 17:00, the patient experienced lips had swollen. Her throat was sore from it, had arm pain and was extremely tired after words. The events did not result in doctor or other healthcare professional office/clinic visit, emergency room/department or urgent care. Therapeutic measures were not taken as a result of the events. On an unknown date, the patient underwent rapid COVID-19 nasal swab test, post vaccination and the result was negative. Since the vaccination, the patient had been tested for COVID-19. The clinical outcomes of the events swollen lips, sore throat, arm pain and extremely tired was recovering at the time of this report. No follow-up attempts are needed; information about lot/batch number cannot be obtained.

Other Meds:

Current Illness: Allergy to nuts (Known allergies: Hazel nut, cashews)

ID: 1652226
Sex: F
Age: 35
State: HI

Vax Date: 02/01/2021
Onset Date: 08/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 026LZOA
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Vomiting

Symptoms: DOB: 07/12/1985 Dept/Mgr: Float pool (NA) Resolution of Symptoms: ongoing Covid-19 Vaccine Yes/No: Yes Date of last dose: 02/13/21 Notes: EE calling to report +COVID result today from 8/26/21 specimen. EE still with congestion and cough. Last took symptom-reducing meds 8/27. Advised EE to quarantine for 10d from symptom onset (8/26) and to call EH back on 9/6 to report on S/S.

Other Meds:

Current Illness:

ID: 1652227
Sex: M
Age: 38
State: AR

Vax Date: 08/13/2021
Onset Date: 08/20/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: SYR
Vax Site: LA

Lab Data:

Allergies: None

Symptom List: Headache, Limb discomfort, Nasal congestion

Symptoms: Persistent muscle pain in back and neck on same side as injection

Other Meds: Lexapro

Current Illness: None

ID: 1652228
Sex: F
Age: 34
State: SC

Vax Date: 08/27/2021
Onset Date: 08/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: PFIZER\BIONTECH
Vax Name: COVID19 (COVID19 (PFIZER-BIONTECH))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Back pain, Cold sweat, Headache, Nausea, Vomiting

Symptoms: Headache, fever, hallucinations, chills, body aches

Other Meds:

Current Illness:

ID: 1652229
Sex: F
Age: 51
State: NH

Vax Date: 08/01/2021
Onset Date: 08/26/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 025j20-2A
Dose Series: 1
Vax Route: IM
Vax Site: LA

Lab Data:

Allergies:

Symptom List: Injection site swelling, Limb discomfort

Symptoms: Vaginal bleeding after 2 years without a period.

Other Meds: Fluoxetine, vitamin d, vitamin b, migra-defense, candesarten, magnesium, omega 3 fatty acids, excedrin migraine.

Current Illness:

ID: 1652230
Sex: M
Age: 0
State:

Vax Date: 08/27/2021
Onset Date: 08/27/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot:
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies:

Symptom List: Chills, Diarrhoea, Fatigue, Feeling abnormal, Headache

Symptoms: Pt was seated in the waiting area (the shot was administered in our "shot room" and the pt was beginning his 15 minute observation period in the waiting area.) He slumped to the right. He was breathing but unresponsive. We guided him to the floor. His face was becoming red in color, and he was still unresponsive. After hearing two wheezing breaths I administered one dose of (Teva branded) epinephrine. Emergency Med Tech arrived about 90 seconds after the dose was administered and took over from there. Pt became fully alert shortly after the EMT arrived. Pt was transported via stretcher from the store.

Other Meds:

Current Illness:

ID: 1652231
Sex: M
Age: 33
State: NY

Vax Date: 08/22/2021
Onset Date: 08/23/2021
Rec V Date: 08/28/2021
Hospital:

Vax Type: COVID19
Manufacturer: MODERNA
Vax Name: COVID19 (COVID19 (MODERNA))
Lot: 037K20A
Dose Series: 1
Vax Route: IM
Vax Site: RA

Lab Data:

Allergies: None

Symptom List: Hot flush, Myalgia, Nausea, Tension headache

Symptoms: I felt fine the day of the vaccine. However the very next day before noon I started feeling very lightheaded and dizzy. That lightheaded and dizzy feeling has not gone away. I have never felt this before.

Other Meds: Men's Multivitamin, Whey Protein isolate, creatine, a preworkout from time to time. No medications/prescriptions. Only dietary supplements.

Current Illness: None

Total 2021 VAERS Injuries: 654,986

Page last modified: 13 November 2021 9:17am